IL-2 RECEPTOR FRAGMENT (HUMAN)
CAS102579-44-2
IL-2 RECEPTOR FRAGMENT (HUMAN) (CAS 102579-44-2, C59H113N29O16) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 102579-44-2
- Formula
- C59H113N29O16
- Mol. weight
- 1484.7 g/mol
Chemical Specifications
Identifiers
| CAS number | 102579-44-2 |
|---|---|
| Product name | IL-2 RECEPTOR FRAGMENT (HUMAN) |
| Synonyms | IL-2 RECEPTOR FRAGMENT (HUMAN); H-GLN-ARG-ARG-GLN-ARG-LYS-SER-ARG-ARG-THR-ILE-OH; GLN-ARG-ARG-GLN-ARG-LYS-SER-ARG-ARG-THR-ILE |
| Molecular formula | C59H113N29O16 |
| Molecular weight | 1484.7 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of IL-2 RECEPTOR FRAGMENT (HUMAN)?
The CAS Registry Number of IL-2 RECEPTOR FRAGMENT (HUMAN) is 102579-44-2. IL-2 RECEPTOR FRAGMENT (HUMAN) is also known as IL-2 RECEPTOR FRAGMENT (HUMAN); H-GLN-ARG-ARG-GLN-ARG-LYS-SER-ARG-ARG-THR-ILE-OH; GLN-ARG-ARG-GLN-ARG-LYS-SER-ARG-ARG-THR-ILE.
What is the molecular formula and molecular weight of IL-2 RECEPTOR FRAGMENT (HUMAN)?
The molecular formula of IL-2 RECEPTOR FRAGMENT (HUMAN) is C59H113N29O16, and its molecular weight is 1484.7 g/mol.
How can I request a quotation for IL-2 RECEPTOR FRAGMENT (HUMAN)?
Send an inquiry for IL-2 RECEPTOR FRAGMENT (HUMAN) (CAS 102579-44-2) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for IL-2 RECEPTOR FRAGMENT (HUMAN)
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.